Article
PCSK9 Protein and rs562556 Polymorphism Are Associated With Arterial Plaques in Healthy Middle-Aged Population: The STANISLAS Cohort.
Journal of the American Heart Association - 7 Apr 2020
Ferreira João Pedro, Xhaard Constance, Lamiral Zohra, Borges-Canha Marta, Neves João Sérgio, Dandine-Roulland Claire, LeFloch Edith, Deleuze Jean-François, Bacq-Daian Delphine, Bozec Erwan, Girerd Nicolas, Boivin Jean-Marc, Zannad Faiez, Rossignol Patrick
Abstract excerpt
Background PCSK9 (Proprotein convertase subtilisin/kexin type 9) binds low-density lipoprotein receptor, preventing its recycling. PCSK9 is a risk predictor and a biotarget in atherosclerosis. The PCSK9-rs562556 variant has been reported as a gain-of-function mutation. The aim of this study was to determine whether the PCSK9-low-density lipoprotein receptor-rs562556 axis is associated with carotid artery plaques...
Read the complete abstract on PubMed